SpringWorks Therapeutics Inc (NASDAQ: SWTX) is 12.07% higher on its value in year-to-date trading and has touched a low of $28.21 and a high of $53.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SWTX stock was last observed hovering at around $41.20 in the last trading session, with the day’s loss setting it -0.71%.
Currently trading at $40.49, the stock is 7.20% and 9.75% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.08 million and changing -1.72% at the moment leaves the stock 5.56% off its SMA200. SWTX registered -2.50% loss for a year compared to 6-month gain of 2.40%. The firm has a 50-day simple moving average (SMA 50) of $36.6684 and a 200-day simple moving average (SMA200) of $38.4102.
The stock witnessed a -2.57% loss in the last 1 month and extending the period to 3 months gives it a 24.93%, and is 12.07% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.99% over the week and 5.58% over the month.
SpringWorks Therapeutics Inc (SWTX) has around 305 employees, a market worth around $3.01B and $135.49M in sales. Profit margin for the company is -203.09%. Distance from 52-week low is 43.53% and -24.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.12%).
with sales reaching $55.22M over the same period.The EPS is expected to grow by 39.43% this year, but quarterly earnings will post 3,322.86% year-over-year. Quarterly sales are estimated to grow 913.70% in year-over-year returns.
322.0 institutions hold shares in SpringWorks Therapeutics Inc (SWTX), with institutional investors hold 118.21% of the company’s shares. The shares outstanding are 74.34M, and float is at 65.88M with Short Float at 17.75%. Institutions hold 115.94% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.11 million shares valued at $418.6 million. The investor’s holdings represent 15.0638 of the SWTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 6.54 million shares valued at $246.53 million to account for 8.8715 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.62 million shares representing 7.6174 and valued at over $211.68 million, while DEEP TRACK CAPITAL, LP holds 5.0157 of the shares totaling 3.7 million with a market value of $139.38 million.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
The most recent transaction is an insider sale by Edris Badreddin, the company’s Chief Operating Officer. SEC filings show that Edris Badreddin sold 20,000 shares of the company’s common stock on Dec 03 ’24 at a price of $41.97 per share for a total of $0.84 million. Following the sale, the insider now owns 0.21 million shares.
SpringWorks Therapeutics Inc disclosed in a document filed with the SEC on Dec 02 ’24 that Islam Saqib (Chief Executive Officer) sold a total of 49,000 shares of the company’s common stock. The trade occurred on Dec 02 ’24 and was made at $41.37 per share for $2.03 million. Following the transaction, the insider now directly holds 1.01 million shares of the SWTX stock.
Still, SEC filings show that on Sep 03 ’24, Islam Saqib (Chief Executive Officer) disposed off 49,000 shares at an average price of $40.57 for $1.99 million. The insider now directly holds 1,063,368 shares of SpringWorks Therapeutics Inc (SWTX).
